We want to understand the molecular basis of stroke pathology in order to advance treatment. To reach this goal, we pursue different approaches. We focus on immune mechanisms, cellular communication, endothelial dysfunction and novel imaging techniques. Novel therapies include nanobodies, which are tested in international preclinical randomized controlled trials.
